By raising ₹500-600 crore, this firm aims to strengthen its market position and adapt to evolving global trends.

Maze Therapeutics, a clinical-stage biopharmaceutical company, launched its initial public offering (IPO) today, with shares ...

Financial services firm DailyPay has begun preparations for a potential listing on the U.S. stock market. The move could occur as early as the second half of this year, according to a Friday report by ...

NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings. Titan America - Brussels, 24 ...

On January 10, 2025, the United States Court of Appeals for the Ninth Circuit Court affirmed the dismissal of a putative securities class ...

Metsera, along with Maze Therapeutics, gave U.S. health care first-time share sales its best month since October.

Underwriters have a 30-day option to buy an additional 1.8 million shares. Beta Bionics also agreed to sell 1 million shares in a private placement to an existing investor at $17 per share. Beta ...

The future of Portugal's Novo Banco is taking a clearer shape as US private equity firm Lone Star signals its intention to pursue an initial public offering (IPO) for a stake of up to 30% in the ...

Five years ago on Thursday, the World Health Organization declared a ‘public health emergency of international concern’: covid-19.We all have our ...

Rapid adoption of generative AI technologies raises complex questions around intellectual property, copyright, and responsib ...

The IPO comes amid a deregulatory push in the energy sector by President Donald Trump, who repeated the "drill, baby, drill" slogan in his inaugural address. Earlier this week, Sean Duffy, the newly ...

U.S. private equity firm Lone Star has told the Portuguese government that it is likely to sell a 25-30% stake in Novo Banco ...